<?xml version="1.0" encoding="UTF-8"?>
<p>Another potential GAS vaccine target is the secreted cholesterol-dependent cytolysin (CDC) streptolysin O (SLO). SLO contributes to virulence [
 <xref rid="pone.0235139.ref025" ref-type="bibr">25</xref>] and orthologues are encoded in the genomes of a wide range of bacteria [
 <xref rid="pone.0235139.ref026" ref-type="bibr">26</xref>] including 
 <italic>Streptococcus pneumoniae</italic> (pneumolysin; PLY), which has historically been the most frequent cause of IAV superinfections [
 <xref rid="pone.0235139.ref027" ref-type="bibr">27</xref>]. Passive immunotherapy with anti-PLY antibodies protects mice against 
 <italic>S</italic>. 
 <italic>pneumoniae</italic> bacteremia [
 <xref rid="pone.0235139.ref028" ref-type="bibr">28</xref>], indicating that the cytolytic CDC toxins may be good candidates for passive immunotherapy targeting bacterial pathogens associated with IAV superinfections.
</p>
